Russell-Jones, R <br/><br/>
The chances of a patient with melanoma developing in transit disease are doubled by undergoing sentinel lymph node biopsy (SLNB).  [electronic resource] 

 -  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology  Mar 2005 
 - 210-1 p.  digital 
<br/><br/> Publication Type: Comment; Letter 
<br/><br/><label>ISSN: </label>0748-7983 
<br/><br/><label>Standard No.: </label>10.1016/j.ejso.2004.10.009  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Humans<br/>Lymph Node Excision<br/>Lymphatic Metastasis<br/>Melanoma--epidemiology<br/>Neoplasm Recurrence, Local--epidemiology<br/>Neoplasm Staging<br/>Sentinel Lymph Node Biopsy<br/>Skin Neoplasms--epidemiology